DEA Proposes Less Opioid Production, More Marijuana for Research in 2020
The Drug Enforcement Administration (DEA) is proposing a reduction in the amount of Schedule II controlled substances that can be manufactured in the US next year.
The Drug Enforcement Administration (DEA) is proposing a reduction in the amount of Schedule II controlled substances that can be manufactured in the US next year.
Settlement talks with OxyContin maker Purdue Pharma over its role in the U.S. opioid crisis have reached a stalemate and the company is expected to file for bankruptcy.
The incidence of neonatal abstinence syndrome has steadily and notably increased in Canada and researchers believe this increase highlights the importance of implementing integrated care for the mother-infant dyad during and after the birth process.
Prenatal opioid exposure is negatively associated with neurocognitive and physical development in offspring from the age of 6 months into school age.
Physicians who receive direct pharmaceutical payments for opioid prescribing prescribe more opioids, especially hydrocodone and oxycodone.
The risk for infective endocarditis related to injection drug use increased from 2006 to 2015.
The percentage of individuals prescribed an opioid is higher in rural than urban areas.
Pediatricians need to ask about nonprescription substance use during pregnancy when taking histories from mothers with opioid dependence to better care for their newborns.
If you prescribe opioids to your patients, be sure to help them avoid addiction.
Chronic opioid use during pregnancy that causes neonatal abstinence syndrome is associated with smaller neonatal head circumference.